Home : DrugWatch : Comtan : Newsfeeds

Comtan - Newsfeeds

Parkinson's Drug May Cause Prostate Cancer
The U.S. Food and Drug Administration says it's evaluating a clinical trial that suggests taking Stalevo may place people at risk of getting prostate cancer. Stalevo (entacapone) is used to treat symptoms of Parkinson's disease. The long-term trial ...
Potential Prostate Cancer Risk with Parkinson’s ...
Stalevo, a combination of three drugs – entacapone, carbidopa and levodopa, is used in the treatment of Parkinson’s disease. In a clinical trial called Stalevo Reduction in Dyskinesia Evaluation – Parkinson’s Disease (STRIDE-PD), patients ...
UPDATE 2-Orion shares sink on news of FDA drug probe
The patents of Orion's key Parkinson's drugs, Stalevo and Comtan, will start to expire in 2012. Orion Chief Executive Timo Lappalainen said he did not know when the probe would be completed. "We have not seen this is as such a significant matter that ...
Modern treatment for Parkinson's disease improves the well-being and ...
Stalevo(*), a combination of levodopa, carbidopa and entacapone, is indicated in the treatment of adult patients suffering from idiopathic Parkinson's disease to substitute for immediate-release levodopa-carbidopa and entacapone, previously ...
Orion Corporation Withdraws Its Application For An Extension Of ...
The European Medicines Agency (EMEA) has been formally notified by Orion Corporation of its decision to withdraw its application for an extension of indication for the centrally authorised medicine Stalevo (levodopa/carbidopa/entacapone) film-coated ...
DJ Wockhardt:Have 180-Day Exclusive Comtan, Stalevo Sales Right
Stalevo is a combination of carbidopa, levodopa and entacapone for the treatment of Parkinson's disease. In the U.S., Comtan had annual sales of $87 million and Stalevo of $113 million, Wockhardt said, citing data from market research firm IMS Health
Buy Wockhardt Around Rs 136.60: VK Sharma
Wockhardt together with its US division executed a settlement and license contract with Orion Corporation regarding Wockhardt`s submission of Abbreviated New Drug Applications (ANDAs) for the generic versions of Orion`s Comtan and Stalevo products. In ...
Finnish Orion files U.S. lawsuit to protect key drug
HELSINKI, Nov 12 (Reuters) - Finnish drug firm Orion ( ORNBV.HE ) said on Wednesday it has filed a patent infringement lawsuit in the United States to protect its key drug Comtan, used for treatment of Parkinson's disease. India's Sun Pharma Global ...
INDIA'S WOCKHARDT SETTLES DRUG PATENT DISPUTE WITH ORION
The company has executed a settlement and licence agreement with Orion Corporation regarding Wockhardt's application before the US drug regulator for the generic version of European firm's Comtan and Stalevo products, the MUMBAI-based drug major ...
Growth in the Parkinson's Disease Drug Market, Fueled by the Launch of ...
Market growth will also be constrained by the generic erosion of other key therapies, including Novartis/Orion Pharma's Comtan/Comtess/Stalevo and Teva Pharmaceuticals/Lundbeck's Agilect/Azilect. According to the report, market sales will also be ...
Parkinson's medications may help treat extreme drug-resistant TB
"Although we have demonstrated in the lab that Comtan is active against M.tuberculosis, additional studies are required in order to transform it into an anti-tubercular therapeutic," said Sarah L. Kinnings, a graduate student and lead author on the ...
Acadia Pharma On A High
Azilect logged in sales of $175 million, while Comtan grossed $502 million in sales in 2008. According to Jason Napodano, a Senior Equity Research Analyst at Zacks, Pimavanserin has the potential to generate sales of $200 million for the ...
Do you need a Comtan attorney in District of Columbia? Contact one of our Comtan attorneys in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need A Comtan Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need a Comtan attorney in District of Columbia? Contact one of our Comtan attorneys in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Comtan Case - Submit Your Information Below

Do you need legal assistance with your Comtan case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Comtan Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.